Literature DB >> 12011450

Negative selection of thymocytes expressing the D10 TCR.

Derek B Sant'Angelo1, Charles A Janeway.   

Abstract

We have analyzed the patterns of positive and negative selection of thymocytes expressing the T cell antigen receptor (TCR) from the D10.G4.1 T cell clone. This TCR confers reactivity to several non-self MHC class II alleles with a remarkably broad range of avidities. Therefore, negative selection can be studied when induced by high-, intermediate-, or low-avidity interactions with endogenous peptide-MHC complexes, all within the same TCR transgenic system. These data directly demonstrate that MHC class II-peptide ligands that fail to activate mature T cells can promote negative selection of immature thymocytes. Additionally, we show that negative selection of thymocytes can occur at two distinct "time points" during development depending on the avidity of the TCR for the MHC-peptide complex. Finally, we show that the self-peptide repertoire plays a significant role in selection because alteration of the self-peptide repertoire by disruption of the H2-Ma gene drastically alters selection of D10 TCR-expressing thymocytes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12011450      PMCID: PMC124506          DOI: 10.1073/pnas.102182499

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  58 in total

1.  A role for accessibility to self-peptide-self-MHC complexes in intrathymic negative selection.

Authors:  C Viret; D B Sant'Angelo; X He; H Ramaswamy; C A Janeway
Journal:  J Immunol       Date:  2001-04-01       Impact factor: 5.422

2.  On the role of high- and low-abundance class II MHC-peptide complexes in the thymic positive selection of CD4(+) T cells.

Authors:  B Chmielowski; P Muranski; P Kisielow; L Ignatowicz
Journal:  Int Immunol       Date:  2000-01       Impact factor: 4.823

Review 3.  The thymus and central tolerance.

Authors:  H Kishimoto; J Sprent
Journal:  Clin Immunol       Date:  2000-04       Impact factor: 3.969

4.  Receptor editing in developing T cells.

Authors:  M A McGargill; J M Derbinski; K A Hogquist
Journal:  Nat Immunol       Date:  2000-10       Impact factor: 25.606

5.  Premature TCR alpha beta expression and signaling in early thymocytes impair thymocyte expansion and partially block their development.

Authors:  H D Lacorazza; C Tucek-Szabo; L V Vasović; K Remus; J Nikolich-Zugich
Journal:  J Immunol       Date:  2001-03-01       Impact factor: 5.422

Review 6.  The ligand for positive selection of T lymphocytes in the thymus.

Authors:  K A Hogquist; S C Jameson; M J Bevan
Journal:  Curr Opin Immunol       Date:  1994-04       Impact factor: 7.486

7.  Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes.

Authors:  P Kisielow; H Blüthmann; U D Staerz; M Steinmetz; H von Boehmer
Journal:  Nature       Date:  1988-06-23       Impact factor: 49.962

8.  Unexpected expression of a unique mixed-isotype class II MHC molecule by transfected L-cells.

Authors:  R N Germain; H Quill
Journal:  Nature       Date:  1986 Mar 6-12       Impact factor: 49.962

9.  Both a monoclonal antibody and antisera specific for determinants unique to individual cloned helper T cell lines can substitute for antigen and antigen-presenting cells in the activation of T cells.

Authors:  J Kaye; S Porcelli; J Tite; B Jones; C A Janeway
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

10.  The Fab fragment of a directly activating monoclonal antibody that precipitates a disulfide-linked heterodimer from a helper T cell clone blocks activation by either allogeneic Ia or antigen and self-Ia.

Authors:  J Kaye; C A Janeway
Journal:  J Exp Med       Date:  1984-05-01       Impact factor: 14.307

View more
  8 in total

1.  Priming with very low-affinity peptide ligands gives rise to CD8(+) T-cell effectors with enhanced function but with greater susceptibility to transforming growth factor (TGF)β-mediated suppression.

Authors:  Jeremy A O'Sullivan; Andrew Zloza; Frederick J Kohlhapp; Tamson V Moore; Andrew T Lacek; Nickolai O Dulin; José A Guevara-Patiño
Journal:  Cancer Immunol Immunother       Date:  2011-06-17       Impact factor: 6.968

Review 2.  The role of the thymus in tolerance.

Authors:  Adam D Griesemer; Eric C Sorenson; Mark A Hardy
Journal:  Transplantation       Date:  2010-09-15       Impact factor: 4.939

3.  Harnessing endogenous miR-181a to segregate transgenic antigen receptor expression in developing versus post-thymic T cells in murine hematopoietic chimeras.

Authors:  Eirini P Papapetrou; Damian Kovalovsky; Laurent Beloeil; Derek Sant'angelo; Michel Sadelain
Journal:  J Clin Invest       Date:  2008-12-01       Impact factor: 14.808

Review 4.  T-helper cell tolerance to ubiquitous nuclear antigens.

Authors:  B Nakken; K E Davis; Z J Pan; M Bachmann; A D Farris
Journal:  Scand J Immunol       Date:  2003-11       Impact factor: 3.487

5.  T cells with low avidity for a tissue-restricted antigen routinely evade central and peripheral tolerance and cause autoimmunity.

Authors:  Dietmar Zehn; Michael J Bevan
Journal:  Immunity       Date:  2006-08-03       Impact factor: 31.745

6.  TCR affinity for self-ligands influences the development and function of encephalitogenic T cells.

Authors:  Jianwei Li; Omar Vandal; Derek B Sant'Angelo
Journal:  PLoS One       Date:  2011-03-17       Impact factor: 3.240

7.  ROS stress resets circadian clocks to coordinate pro-survival signals.

Authors:  Teruya Tamaru; Mitsuru Hattori; Yasuharu Ninomiya; Genki Kawamura; Guillaume Varès; Kousuke Honda; Durga Prasad Mishra; Bing Wang; Ivor Benjamin; Paolo Sassone-Corsi; Takeaki Ozawa; Ken Takamatsu
Journal:  PLoS One       Date:  2013-12-02       Impact factor: 3.240

8.  Autoreactive T cells bypass negative selection and respond to self-antigen stimulation during infection.

Authors:  Sarah Enouz; Lucie Carrié; Doron Merkler; Michael J Bevan; Dietmar Zehn
Journal:  J Exp Med       Date:  2012-09-17       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.